pharmaphorum

FEBRUARY 17, 2022

Akili Interactive’s prescription gaming app for attention deficit hyperactivity disorder (ADHD) EndeavorRx has been show to enhance neuronal activity in an area of the brain associated with attention function. The results come from a single-arm, unblinded study of the app, but add to the clinical evidence that EndeavorRx can have a positive impact on children with ADHD which led it to become the prescription game to be approved by the FDA in 2020.

FDA 138

FDA 138

Outsourcing Pharma

FEBRUARY 17, 2022

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

115

115

Fossil Remedies

FEBRUARY 18, 2022

PCD Pharma Franchise Business. Why are more aspirants willing to make a career in the field of pharmaceuticals? It is because the business is not only promising, but it is going to remain profitable for many years. People have become health conscious and they want to maintain fitness. Also, the recent Covid-19 outbreak has also changed the scenario.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharma Times

FEBRUARY 18, 2022

New combination treatment can significantly reduce the risk of death among prostate cancer patients

58

58

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

FEBRUARY 18, 2022

The pandemic-induced transition to digital health is, according to the Nuffield Trust, contributing to an “inverse care law” that’s compounding existing health inequalities. But, as demonstrated by initiatives like the Telehealth Equity Coalition (TEC), the sector is taking a united stand against inequitable access. Technological solutions, from online clinics to app-based long-term condition management, have long been hailed as a solution to problems such as limited capacity and low patient aut

Compounding 132

Compounding 132

Outsourcing Pharma

FEBRUARY 15, 2022

An expert from the institutional review board services company advises what trends to look for in the clinical trial industry over the course of coming months.

100

100

Pharma Times

FEBRUARY 15, 2022

Francis Crick Institute and King’s College London collaborate to identify specialist cells which protect DNA

Immunization 55

Immunization 55

pharmaphorum

FEBRUARY 18, 2022

Sanofi and Regeneron have reported disappointing results in a trial of Dupixent in people with chronic spontaneous urticaria (CSU) who don’t respond to the only approved biologic treatment, Novartis/Roche’s Xolair. . CSU is a severe form of hives that affects around 1% of the global population, causing severe itching and swelling that can last for weeks at a time and resist even very high doses of antihistamines, the standard, first-line therapy for the condition.

105

105

Outsourcing Pharma

FEBRUARY 15, 2022

The institute and the research/support organization will collaborate on development of novel therapies aimed at treating the central nervous system disorder.

92

92

Pharma Mirror

FEBRUARY 18, 2022

Dean Kavanagh, Managing Director of QED Environmental Systems Ltd in the UK, has been appointed Co-Chair of the Council of Gas Detection and Environmental Monitoring (CoGDEM) Industry Subgroup. Dean will chair the Sub-group with Rob White, Sales Director of DD Scientific, with both chairs taking up their appointments early in 2022. The CoGDEM Industry Subgroup is one of the most influential steering groups, with meetings scheduled three times a year.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

FEBRUARY 15, 2022

Oxford university spin out company develops tech to identify viruses in seconds

54

54

pharmaphorum

FEBRUARY 15, 2022

One in four of the world’s rivers are polluted with potentially toxic levels of pharma compounds, according to a new study. The findings point to a “threat to environmental and global health,” say the scientists, who found that paracetamol, antibiotics epilepsy drug carbamazepine, metformin for diabetes and other compounds like caffeine and nicotine were found in samples from around the world – including in Antarctica.

Compounding 105

Compounding 105

Outsourcing Pharma

FEBRUARY 14, 2022

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

69

69

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The pharmaceutical industry works hard to create cutting-edge drugs to save lives and keep people healthy. From research to clinical trials, to go-to-market, drug makers are constantly seeking out new drug technologies and approaches to treat everyday illnesses and to end global pande

Packaging 52

Packaging Vaccines 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Marketing Network

FEBRUARY 18, 2022

Join PMN and industry experts from Novo Nordisk, Esai, GSK, Otsuka and more for part 1 of a 2 part series on engagement. The PMN HCP Engagement Summit , 03/02/2022 @ 12PM EST, will focus on HCP Engagement on the following panel topics: Modular Content: Making It Work. Get insights for pharma marketing insiders on restructuring you content strategy allowing more flexibility and agility to deliver more relative content to your customers.

52

52

pharmaphorum

FEBRUARY 18, 2022

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic hormone-sensitive tumours. The optimistic assessment of the revenue potential for androgen receptor inhibitor Nubeqa (darolutamide) follows the publication of the results of the phase 3 ARASENS trial in the New England Journal of Medicine.

Chemotherapy 98

Chemotherapy Labelling 98

Outsourcing Pharma

FEBRUARY 14, 2022

Cullinan Oncology has formed a strategic partnership with the Icahn School of Medicine at Mount Sinai to research and develop targeted therapies for cancer.

64

64

Roots Analysis

FEBRUARY 18, 2022

Myeloid cells represent a group of cells containing granulocytes, monocytes, macrophages, mast cells and dendritic cells, which play a key role in innate immunity. These cells are found in abundance in the tumor microenvironment and inflamed areas. The tumor recruits and modulates endogenous myeloid cells to tumor-associated macrophages, dendritic cells, myeloid-derived suppressor cells and neutrophils, to sustain an immunosuppressive environment.

Immunization 52

Immunization Vaccines 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmD Live

FEBRUARY 17, 2022

By Richard Korecky, PharmD, BCGP. COVID-19 has profoundly changed the world we live in today and will continue to leave an indelible mark long after the pandemic has ended. One area of concern for both health care providers and their patients is the long-term effect of COVID-19 infection on patients with chronic diseases. Acute cardiac injury has been a well-documented feature of infection with SARS-CoV-2, which causes COVID-19 among patients requiring hospitalization.

Hospitals 52

Hospitals Documentation Labelling 52

pharmaphorum

FEBRUARY 16, 2022

An unexpected benefit of healthcare professional (HCP) engagement going digital in 2020 is that sales teams have more opportunities to spend quality time with doctors. Compared to traditional, face-to-face meetings, virtual meetings extended the amount of time HCPs were able to spend meeting with reps from an average of three minutes to 19 minutes. While the chance to engage in more meaningful conversations with doctors is a positive step for sales teams, marketers are under significant pressure

98

98

Outsourcing Pharma

FEBRUARY 14, 2022

In this second of a two-part series, experts from the clinical research organization share thoughts on how data management technology, personnel, and partnerships have evolved.

59

59

Pharma Mirror

FEBRUARY 17, 2022

The importance of exosomes in skin cell regeneration has been extensively researched over the past few years. Functions involving the fibroblasts, forming of new blood vessels, and controlling the localized inflammatory response of the skin are all benefits of their use. Exosomes have another essential function, and that would be intercellular communication.

Communication 52

Communication 52

Pharmig

FEBRUARY 16, 2022

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post The history of pharmaceutical microbiology appeared first on Pharmig.

52

52

pharmaphorum

FEBRUARY 14, 2022

A recent report has found that R&D productivity rose vertiginously during 2021, but how much of this was organic and how much can be attributed to the pandemic? In this feature, Ben Hargreaves looks at all of the factors involved and how the increased return can be maintained. The pharma industry has had a difficult time solving the issue of achieving greater productivity without significantly increasing the cost it takes to discover and commercialise new products.

Vaccines 98

Vaccines 98

Outsourcing Pharma

FEBRUARY 17, 2022

This monthâs list of announcements about technology, funding, and more includes Medable, Clarify Health, Thermo Fisher Scientific, and other key companies.

52

52

Pharma Mirror

FEBRUARY 17, 2022

Although many labs are doing cutting-edge research and finding new ways to improve life in this world, they aren’t always the picture of productivity. Unfortunately, some labs are not very well organized internally and often could find ways to be more productive. Resources are often very limited so it makes sense to work on being more productive and wasting fewer resources to get the job done.

52

52

NICE

FEBRUARY 16, 2022

NICE is working in partnership with the Care Quality Commission, Health Research Authority and Medicines and Healthcare products Regulatory Agency to deliver a multi-agency advisory service (MAAS) for developers and adopters of data-driven technologies, such as artificial intelligence (AI). This innovative new cross-regulatory service will provide support on the regulation and evaluation of AI technologies in health and care.

52

52

pharmaphorum

FEBRUARY 13, 2022

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic candidates as early as possible in the drug discovery process. Quris’ BioAI safety prediction platform – which is based on human tissue samples on chips, nanosensors and machine learning – will be compared to traditional in vitro and in vivo laboratory techniques for spotting toxicity.

Compounding 98

Compounding 98

Outsourcing Pharma

FEBRUARY 17, 2022

Created via a joint effort with EY, the pharmaceutical company launched ASPIREs, a program intended to improve its clinical trial processes in numerous areas.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Spirit Pharmacist

FEBRUARY 16, 2022

Bridging the Gap: Navigating Psychotropics and Psychedelics. As psychedelics therapies rapidly emerge as treatments for mental health conditions, many are interested in use. However, some psychotropic medications can interfere with benefits or increase risks. Sometimes these interactions are significant enough to warrant taper and discontinuation, whereas sometimes they aren't.

52

52

Roots Analysis

FEBRUARY 16, 2022

In earlier times, container closure integrity testing was not regarded as an essential step in the process of manufacturing. The company developing drug product through such an intense process, use to consider container closure system only for packaging of the product. [1] However, gradually it was realized that container closure integrity is a key factor that maintains product stability and sterility throughout its shelf life.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

FEBRUARY 15, 2022

Digital health startup Bia Care has been awarded additional funding from the NHS to extend the rollout of its virtual clinic providing remote care for women going through the menopause. The London-based company launched the digitally-enabled service last year, allowing women to book an appointment, have a group online consultation with a doctor, get a personalised plan for managing menopause and – if needed – get treatments delivered to their homes.

75

75

NICE

FEBRUARY 14, 2022

What is a NICE research recommendation? As NICE develops any of its guidance products, we identify gaps and uncertainties in the evidence base which could benefit from further research. The most important unanswered questions are developed into research recommendations. How do NICE & NIHR work together? NIHR have been screening NICE guidance for nearly 20 years to identify topics suitable for commissioning research.

52

52